NYSE Content Update: AdvanCell Raises $315 Million to Fight Prostate Cancer
NYSE Content Update: AdvanCell Raises $315 Million to Fight Prostate Cancer
PR Newswire
NEW YORK, July 17, 2026
NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, July 17, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Ashley Mastronardi delivers the pre-market update on July 17th
- Equities are lower as investors parse through fresh earnings and monitor new activity in the Middle East.
- NYSE Live will provide exclusive access to Standard Nuclear's executive remarks.
- CEO Kurt Terrani will also join the program to explain why now was the perfect time to take the energy company public.
- Shares of STDN began trading on Thursday.
- AdvanCell CEO Philina Lee joins NYSE Live following the firm's $315 million funding round.
- Startup is developing targeted alpha therapies for prostate cancer.
- Company says it will be expanding its manufacturing infrastructure in the U.S.
- Voyager Technologies discloses next steps after receiving a $298 million contract from NASA.
- Firm will conduct pair of lunar landing missions following its acquisition of Astrobotic.
- Chairman + CEO Dylan Taylor will join NYSE Live to discuss how the data will aid NASA's Artemis program.
Opening Bell
Standard Nuclear (NYSE: STDN) celebrates its recent Initial Public Offering
Closing Bell
UWM Holdings (NYSE: UWMC) celebrates of National Mortgage Brokers Day
For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com
SOURCE New York Stock Exchange
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
United States